15 October 2013 Plethora Solutions Holdings PLC ("Plethora" or the "Company") Exercise of warrant

Plethora Solutions Holdings plc (AIM: PLE) announces that it has received notice from the holder of a warrant to subscribe for 410,000 shares at 10p per share to exercise that warrant.
Application has been made to the London Stock Exchange for the shares arising from the exercise to be admitted to trading. Dealings in the new shares are expected to commence on 21 October 2013.

-Ends- Enquiries: Plethora Solutions

Ronald Openshaw, CEO

Daniel Stewart (Nomad & Joint Broker) David Hart / Ciaran Walsh (Nomad) Martin Lampshire (Broker) Hybridan LLP (Joint Broker)

Claire Louise Noyce

William Lynne

Tel : +44(0) 20 3077 5400 Tel : +44(0) 20 7776 6550 Tel: +44(0) 20 7947 4350 Tel: +44(0) 20 7947 4361 Britton Financial PR

Tim Blackstone

About Plethora: Tel: + 44 (0) 20 7242 9786 +44 (0) 7957 140416

Plethora is headquartered in the UK and is listed on the London Stock Exchange (AIM: PLE.L). Further information is available at www.plethorasolutions.co.uk

Plethora is focussed on seeking to launch PSD502 for the treatment of premature ejaculation.

distributed by